0001179110-20-004006.txt : 20200319 0001179110-20-004006.hdr.sgml : 20200319 20200319211714 ACCESSION NUMBER: 0001179110-20-004006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200317 FILED AS OF DATE: 20200319 DATE AS OF CHANGE: 20200319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saad Mark E CENTRAL INDEX KEY: 0001295913 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37635 FILM NUMBER: 20730011 BUSINESS ADDRESS: BUSINESS PHONE: 858-458-0900 MAIL ADDRESS: STREET 1: C/O CYTORI THERAPEUTICS, INC. STREET 2: 3020 CALLAN ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axsome Therapeutics, Inc. CENTRAL INDEX KEY: 0001579428 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454241907 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BROADWAY, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10038 BUSINESS PHONE: (212) 332-3241 MAIL ADDRESS: STREET 1: 200 BROADWAY, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10038 4 1 edgar.xml FORM 4 - X0306 4 2020-03-17 0 0001579428 Axsome Therapeutics, Inc. AXSM 0001295913 Saad Mark E C/O AXSOME THERAPEUTICS, INC 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 1 0 0 0 Stock Option (Right to Buy) 45.14 2020-03-17 4 A 0 3789 0 A 2020-03-17 2030-03-16 Common Stock 3789 3789 D Represents 3,789 options elected to be received in lieu of cash compensation earned in 2019. All of such options are immediately exercisable. /s/ Herriot Tabuteau, M.D., Attorney in Fact 2020-03-19